September 11, 2012
A New Jersey federal judge Tuesday declared valid the patent behind Johnson & Johnson's Ortho Tri-Cyclen Lo birth control drug, blocking a Lupin Pharmaceuticals Inc. effort to market a generic competitor.
February 08, 2012
Watson Laboratories on Wednesday announced that it has entered into an agreement with a Johnson & Johnson subsidiary by which the company will issue to Watson a generic version of J&J's Ortho Tri-Cyclen Lo birth control drug, days after the parties settled a related patent infringement suit in New Jersey.
January 25, 2011
Ortho-McNeil-Janssen Pharmaceuticals Inc. has beaten back two of Watson Laboratories Inc.'s affirmative defenses in its consolidated patent infringement suit seeking to block Watson and Lupin Pharmaceuticals Inc. from making a generic version of its Ortho Tri-Cyclen Lo contraceptive.